|
Product Description
|
Recall Class
|
FDA Recall Posting Date
|
Recalling Firm
|
TRIDENTII HEMI CLUSTER44B- Indicated for use in primary and revision patients at high risk of hip d...
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
TRIDENTII HEMI CLUSTER48D-indicated for use in primary and revision patients at high risk of hip dis...
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
TRIDENTII HEMI CLUSTER50D- Indicated for use in primary and revision patients at high risk of hip di...
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
TRIDENTII HEMI CLUSTER52E-Indicated for use in primary and revision patients at high risk of hip dis...
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
TRIDENTII HEMI CLUSTER54E- Indicated for use in primary and revision patients at high risk of hip d...
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
TRIDENTII PSL CLUSTER64H- Indicated for use in primary and revision patients at high risk of hip dis...
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
TRIDENTII HEMI CLUSTER66H- Indicated for use in primary and revision patients at high risk of hip d...
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
TRIDENTII PSL CLUSTER48D- Indicated for use in primary and revision patients at high risk of hip di...
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
TRIDENTII PSL CLUSTER50D- Indicated for use in primary and revision patients at high risk of hip dis...
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
TRIDENTII PSL CLUSTER52E- Indicated for use in primary and revision patients at high risk of hip dis...
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|